Cargando…
Mibefradil and Flunarizine, Two T-Type Calcium Channel Inhibitors, Protect Mice against Lipopolysaccharide-Induced Acute Lung Injury
Recent studies have illuminated that blocking Ca(2+) influx into effector cells is an attractive therapeutic strategy for lung injury. We hypothesize that T-type calcium channel may be a potential therapeutic target for acute lung injury (ALI). In this study, the pharmacological activity of mibefrad...
Autores principales: | Wan, Limei, Wu, Weibin, Jiang, Shunjun, Wan, Shanhe, Meng, Dongmei, Wang, Zhipeng, Zhang, Jiajie, Wei, Li, Yu, Pengjiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671802/ https://www.ncbi.nlm.nih.gov/pubmed/33223955 http://dx.doi.org/10.1155/2020/3691701 |
Ejemplares similares
-
Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine
por: Jhang, Kai-Ming, et al.
Publicado: (2017) -
Mibefradil alters intracellular calcium concentration by activation of phospholipase C and IP(3) receptor function
por: Souza Bomfim, Guilherme H., et al.
Publicado: (2021) -
T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines
por: Huang, Weifeng, et al.
Publicado: (2015) -
Mibefradil reduces blood glucose concentration in db/db mice
por: Lu, Yujie, et al.
Publicado: (2014) -
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore
por: Paradkar, Sateja, et al.
Publicado: (2021)